Erythropoietin in Spinocerebellar Ataxia Type 2: Feasibility and Proof‐of‐Principle Issues from a Randomized Controlled Study
Year: 2022
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Movement Disorders
DOI: 10.1002/mds.29045
Authors: Roberto Rodriguez‐Labrada, Ricardo Ortega‐Sanchez, Patricia Hernández Casaña, Orestes Santos Morales, Maria del Carmen Padrón‐Estupiñan, Maricela Batista‐Nuñez, Daise Jiménez Rodríguez, Nalia Canales‐Ochoa, Arnoy Peña Acosta, Jacqueline Medrano Montero, Pedro Enrique Labrada Aguilera, Annelie Estupiñán Rodriguez, Yaimee Vazquez‐Mojena, Dennis Almaguer Gotay, Judey Aymed‐García, Idrian García‐García, Reydenis Torres Vega, Carmen Viada González, Carmen M. Valenzuela Silva, Yanelis Silva Ricardo, Jorge Columbié Ximelis, Kenia Tribin Rivero, Roselin Valle Cabrera, Julio Cesar García‐Rodriguez, Tania Crombet Ramos, Daniel Amaro‐González, Teresita Rodriguez‐Obaya, Luis Velázquez‐Pérez
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4282945262